Article Information
History
- September 24, 2024.
Article Versions
- You are currently viewing Version 1 of this article (September 24, 2024 - 22:34).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Lietsel Jones1,2,*,
- Catalina Cerquera-Cleves3,4,
- Artur FS Schuh5,6,
- Mary B Makarious1,2,
- Hirotaka Iwaki1,2,
- Mike A. Nalls1,2,
- Alastair J Noyce7,
- Global Parkinson’s Genetics Program (GP2),
- Cornelis Blauwendraat1,8,
- Andrew Singleton1,8,
- Ignacio Mata9 and
- Sara Bandres-Ciga1,*
- 1Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
- 2DataTecnica LLC, Washington DC, USA
- 3Department of Neurosciences, Neurology Unit, Hospital Universitario San Ignacio, Bogotá, Colombia
- 4CHU de Québec Research Center, Axe Neurosciences, Université Laval, Quebec City, Canada
- 5Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
- 6Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
- 7Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
- 8Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA
- 9Genomic Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, United States
- ↵*Corresponding author
Lietsel Jones, Center for Alzheimer’s and Related Dementias (CARD), NIA, NIH, DataTecnica LLC, Washington DC, USA, email: lietsel{at}datatecnica.com, Sara Bandres-Ciga, Center for Alzheimer’s and Related Dementias (CARD), NIA, NIH, email: sara.bandresciga{at}nih.gov
Posted September 24, 2024.
Multi-ancestry population attributable risk assessment of common genetic variation in Alzheimer’s and Parkinson’s diseases
